AdvisorShares Psychedelics ETF (PSIL)
17.25
+0.12
(+0.68%)
USD |
NYSEARCA |
Jan 14, 12:27
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 1.00% | -0.33% | 19.28M | 18531.17 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| -- | 107.0% | 6.448M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap Value |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | AdvisorShares |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 14, 2026.
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.30% |
| Stock | 95.97% |
| Bond | 3.72% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Small Cap Value |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | AdvisorShares |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |